NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

CSV download of the complete patent data set.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset the Search Filters to go back to the initial display of all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NHGRI E-034-2019-0-US-07 Targeted Integration Into The Albumin (Alb) Locus As A Treatment For Hereditary Methylmalonic Acidemia (MMA) Caused By Methylmalonyl-coA Mutase (MUT) Deficiency US National Stage 17/267,482 Pending
NCI E-085-2013-0-HK-28 Methods for Producing Enriched Populations of Tumor Reactive T Cells from Peripheral Blood HK CN 42021025138.5 Issued
NCATS E-176-2018-0-PCT-02 TAT PEPTIDE BINDING PROTEINS AND USES THEREOF PCT PCT PCT/US2021/016959 Expired
NIAID E-168-2020-2-PC-01 Corona Virus Binders PCT PCT PCT/EP2021/052885 Expired
NIAID E-168-2020-2-US-01 Corona Virus Binders US National Stage 17/760,300 Pending
NCI E-198-2018-0-US-07 HIGH AFFINITY MONOCLONAL ANTIBODIES TARGETING GLYPICAN-2 AND USES THEREOF US National Stage 17/266,419 Pending
NIAID E-168-2020-2-CN-01 Corona Virus Binders CN National Stage 2021800270795 Pending
NCATS E-176-2018-0-EP-04 TAT PEPTIDE BINDING PROTEINS AND USES THEREOF EP National Stage 21709825.0 Pending
NIAID E-168-2020-2-EP-01 Corona Virus Binders EP National Stage 21712040.1 Pending
NCATS E-176-2018-0-US-02 TAT PEPTIDE BINDING PROTEINS AND USES THEREOF US National Stage 17/796,561 Pending
NIAID E-168-2020-2-HK-01 Corona Virus Binders HK EP 62023071524.0 Pending
NIAID E-168-2020-2-IL-01 Corona Virus Binders IL National Stage 295389 Pending
NCATS E-176-2018-0-IN-03 TAT PEPTIDE BINDING PROTEINS AND USES THEREOF IN National Stage 202217049798 Pending
NIAID E-168-2020-2-JP-01 Corona Virus Binders JP National Stage 2022-548140 Pending
NIAID E-168-2020-2-CA-01 Corona Virus Binders CA National Stage 3166967 Pending
NCATS E-176-2018-0-CA-06 TAT PEPTIDE BINDING PROTEINS AND USES THEREOF CA National Stage 3167027 Pending
NIAID E-168-2020-2-KR-01 Corona Virus Binders KR National Stage 10-2022-7030791 Pending
NCATS E-176-2018-0-KR-05 TAT PEPTIDE BINDING PROTEINS AND USES THEREOF KR National Stage 10-2022-7030361 Pending
NIAID E-168-2020-2-AU-01 Corona Virus Binders AU National Stage 2021217563 Pending
NIAID E-052-2017-4-JP-51 Trispecific And/or Trivalent Binding Proteins For Prevention Or Treatment Of HIV Infection JP DIV 2021-016190 Issued
NIDCR E-186-2009-0-US-09 APOPTOTIC CELL-MEDIATED INDUCTION OF ANTIGEN SPECIFIC REGULATORY T-CELLS FOR THE THERAPY OF AUTOIMMUNE DISEASES IN ANIMALS AND HUMANS US CON 17/167,737 Pending
NIDA E-053-2016-2-US-06 DOPAMINE D3 RECEPTOR SELECTIVE ANTAGONISTS/PARTIAL AGONISTS AND USES THEREOF US National Stage 17/265,150 11337971 Issued PDF
NIAMS E-216-2010-0-US-09 COMPOSITIONS AND METHODS FOR TREATING OR PREVENTING LUPUS US CON 17/162,982 Abandoned
NCATS E-244-2014-0-US-11 Small Molecule Inhibitors Of Lactate Dehydrogenase US CON 17/160,868 11247971 Issued PDF
NCI E-041-2020-0-PCT-02 RAB13 AND NET1 ANTISENSE OLIGONUCLEOTIDES TO TREAT METASTATIC CANCER PCT PCT PCT/US2021/015053 Expired
NIDCD E-029-2020-0-PCT-02 USE OF STATINS TO TREAT OR PREVENT DRUG INDUCED HEARING LOSS PCT PCT PCT/U2021/14918 Expired
NIDCD E-029-2020-0-EP-03 USE OF STATINS TO TREAT OR PREVENT DRUG INDUCED HEARING LOSS EP National Stage 21705831.2 Pending
NIAID E-099-2016-1-US-23 USE OF GRAM NEGATIVE SPECIES TO TREAT ATOPIC DERMATITIS US CON 17/157,761 Abandoned
NCATS E-116-2016-0-US-09 CRYSTAL FORMS AND METHODS OF SYNTHESIS OF (2R, 6R)-HYDROXYNORKETAMINE AND (2S, 6S)-HYDROXYNORKETAMINE US DIV 17/155,162 11613514 Issued PDF
NIDCD E-004-2019-1-PCT-02 ADENO-ASSOCIATED VIRUSES AND THEIR USES FOR INNER EAR THERAPY PCT PCT PCT/US2021/014553 Expired
NCI E-031-2014-0-US-10 PCSK9 VACCINE AND METHODS OF USING THE SAME US CON 17/155,549 Pending
NIDCD E-004-2019-1-CN-04 ADENO-ASSOCIATED VIRUSES AND THEIR USES FOR INNER EAR THERAPY CN National Stage 202180002375.X Pending
NIDCD E-004-2019-1-EP-05 ADENO-ASSOCIATED VIRUSES AND THEIR USES FOR INNER EAR THERAPY EP National Stage 21706093.8 Pending
NIDCD E-004-2019-1-IL-06 ADENO-ASSOCIATED VIRUSES AND THEIR USES FOR INNER EAR THERAPY IL National Stage 285977 Pending
NCI E-181-2018-2-US-04 OXYNITIDINE DERIVATIVES USEFUL AS INHIBITORS OF TOPOISOMERASE IB (TOP1) AND TYROSYL-DNA PHOSPHODIESTERASE 1 (TDP1) US National Stage 17/262,379 Pending
NCI E-233-2014-0-AU-09 Methods of isolating T cell receptors having antigenic specificity for a cancer specific mutation AU DIV 2021200388 Issued
NEI E-164-2018-3-AU-02 INTRAOCULAR DELIVERY OF GENE THERAPY EXPRESSION VECTORS AU National Stage 2019307911 Issued
NCI E-170-2019-0-PCT-02 HUMAN IMMUNOGENIC EPITOPES OF H, K, AND E HUMAN ENDOGENOUS RETROVIRUSES (HERVs) PCT PCT PCT/US2021/014360 Expired
NCI E-159-2019-0-PCT-02 HUMAN IMMUNOGENIC EPITOPES OF HEMO and HHLA2 HUMAN ENDOGENOUS RETROVIRUSES (HERVS) PCT PCT PCT/US2021/014335 Expired
NIAID E-050-2018-0-US-07 NIPAH VIRUS IMMUNOGENS AND THEIR USE US National Stage 17/261,828 11890339 Issued PDF
NCI E-169-2018-0-PCT-02 ARYL HYDANTOIN HETEROCYCLES AND METHODS OF USE PCT PCT PCT/US2021/14176 Expired
NEI E-164-2018-3-JP-05 INTRAOCULAR DELIVERY OF GENE THERAPY EXPRESSION VECTORS JP National Stage 2021-503027 Issued
NIAID E-081-2013-4-CN-16 Prefusion RSV F Proteins And Their Use CN DIV 202110068562.X Pending
NEI E-164-2018-3-CA-03 INTRAOCULAR DELIVERY OF GENE THERAPY EXPRESSION VECTORS CA National Stage 3106869 Pending
NEI E-008-2020-0-PCT-02 GENE THERAPY FOR TREATMENT OF CRX-AUTOSOMAL DOMINANT RETINOPATHIES PCT PCT PCT/US2021/013733 Expired
NHLBI E-070-2020-0-PCT-02 ISOTOPES OF ALPHA KETOGLUTARATE AND RELATED COMPOUNDS FOR HYPERPOLARIZED IMAGING PCT PCT PCT/US2021/013658 Expired
NHLBI E-069-2020-0-PCT-02 REAL-TIME MONITORING OF IN VIVO FREE RADICAL SCAVENGERS THROUGH HYPERPOLARIZED N-ACETYL CYSTEINE ISOTOPES PCT PCT PCT/US2021/013634 Expired
NEI E-164-2018-3-US-06 INTRAOCULAR DELIVERY OF GENE THERAPY EXPRESSION VECTORS US National Stage 17/260,905 Pending
NHLBI E-070-2020-0-EP-03 ISOTOPES OF ALPHA KETOGLUTARATE AND RELATED COMPOUNDS FOR HYPERPOLARIZED IMAGING EP National Stage 21741941.5 Pending
NEI E-008-2020-0-EP-06 GENE THERAPY FOR TREATMENT OF CRX-AUTOSOMAL DOMINANT RETINOPATHIES EP National Stage 21705324.8 Pending